http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5663999-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
filingDate 1979-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c25440c1c5dd4b2cc880a922187f5f52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6576e2785f80ae0855620bb32a298632
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4d21366bb786f5d87e4d17295c2a5dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef09cd6facbd064b64927cfd1025971
publicationDate 1981-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5663999-A
titleOfInvention Separation of hydroxycholesta-5,7-dienes
abstract PURPOSE: To separate the titled compound useful as an intermedate of a remedy for osteomalacia, etc., economically, in an industrial scale, by recrystallizing a mixture of hydroxycholesta-5,7-diene and hydroxycholesta-4,6-diene in a specific mixed solvent. n CONSTITUTION: A mixture of hydroxycholesta-5,7-dienes of formula I (R 1 and R 2 are independently pivaloyl or ethoxycarbonyl; R 3 and R 4 are independently H, pivaloyloxy, or ethoxycarbonyl, provided that R 3 and R 4 are not H at the same time) and hydroxycholesta-4,6-dienes of formula II, is recrystallized with a mixed solvent consisting of a lower aliphatic alcohol (e.g. methanol) and a lower aliphatic ether (e.g. diethyl ether) to obtain the crystal of the objective compound exclusively. n COPYRIGHT: (C)1981,JPO&Japio
priorityDate 1979-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226631659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67253716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411295700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53996943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54178922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411295702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235978295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236253833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70496132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236253832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228184342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70496133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20056519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228184344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824109

Total number of triples: 34.